AEGIS-II (Completed)
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
- Medicine
- CSL112
- Population
- ASCVD
- Phase
- III
- Starting year
- 2017
- More information
- Clinicaltrials.gov